All Pharma articles – Page 16
-
News
Tell trusts whether to outsource this year, says Carter
Lord Carter recommends trusts determine whether their in-house departments are viable this year Urges NHS Improvement to develop benchmarks for admin costs, pharmacy and pathology Methodology used for review has been criticised Trusts should find out this year whether they will be forced to outsource their administration, pathology ...
-
HSJ Local
Pharma companies banned from sponsoring CCG's events
South Warwickshire CCG leaders will no longer allow drug companies to sponsor its events Change driven by recent media reports and staff concerns that pharma representatives at events had “little benefit” COMMERCIAL: Pharmaceutical companies will no longer be allowed to sponsor events organised by South Warwickshire Clinical Commissioning ...
-
News
Efficiency review will point to pharmacy consolidation
Lord Carter believes that £850m-£1.4bn can be saved in pharmacy and medicines management by 2020 Report is expected to recommend trusts review operations for buying, producing and supplying medicines, and consider outsourcing All hospitals will need to adopt electronic prescribing and medicines management systems Lord Carter’s review of ...
-
News
£3bn savings can be made by 2020, hospitals agree
Carter report will restate that £5bn efficiency savings can be achieved by acute sector by 2020 Hospital trusts so far accept they can make £3bn savings in that timescale Reducing delayed transfers of care and service reconfiguration key to unlocking savings, draft report says Hospital trusts have accepted ...
-
Comment
Words: mightier than swords and deadly when misused in labels
Mislabelling can cost lives so it’s high time we made improvements that can prevent it
-
News
'Substantial risk' to specialised care budget, NHS England warns
NHS England warns of high risk that specialised services budgets will be signficantly overspent Due to ‘stream’ of new, expensive treatments Managing this could involve slowing the adoption or spreading the costs of new treatments It could also involve managing demand, including through a focus on variation in use ...
-
News
DH plans big cut to community pharmacy funding
NHS funding to community pharmacies is set to be reduced by 6 per cent in cash terms next year, the Department of Health has announced.
-
News
Exclusive: NHS England attempts to halt judicial review in drug funding row
NHS England faces threat of judicial review over refusal to fund treatment for teenager DH and NHS England are funding Xyrem for hundreds of other narcolepsy patients Lawyers argue the decision is unlawful and discriminatory NHS England has asked doctors to resubmit a bid for funding to treat ...
-
News
Exclusive: NHS England faces judicial review over narcolepsy drug refusal
NHS England has until tomorrow to decide whether to fund narcolepsy treatment for teenager 194 patients have already received NHS funding for Xyrem Lawyers claim the refusal to fund the drug is discriminatory and unlawful NHS England has until tomorrow to decide whether to fund for a teenager ...
-
Supplements
HSJ roundtable: the need to get better at sharing data
There are still shortcomings in the way the NHS shares patient information. HSJ’s latest roundtable came up with some answers
-
Comment
The biggest barrier to stopping HIV transmission is access to drugs
For those at greatest risk
-
Supplements
Excellent care supplement: Taking NHS standards to the next level
Effective management and evidence based care
-
Supplements
Supplement: Think on your feet for the best diabetes care
Give medicines optimisation a chance
-
Supplements
Value and Healthcare Awards: Value and Improvement in Clinical Support Services
Value in Healthcare Awards winners for 2015
-
Supplements
Value in Healthcare Awards: Value and Improvement in Medicines Management
Value in Healthcare Awards winners for 2015